| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |